Schrodinger, Inc. (NASDAQ:SDGR) shares are trading higher on Tuesday. The company disclosed a research collaboration and ...

Cellares, the world's first Integrated Development and Manufacturing Organization (IDMO), and a leader in automated cell therapy manufacturing, has appointed Ossama Eissa, former executive at Novartis ...

Schrödinger today announced a multi-target collaboration and expanded software licensing agreement with Novartis.

Novartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big Pharma will work with Schrödinger to advance some of the computing-enabled R&D shop’s discovery programs ...

Thomas also held leadership posts with Novartis, Bristol-Myers Squibb ... to advance to this critical stage of research,” ...

With the seven-year experience of attending the China International Import Expo, Guan Hong, a senior executive at Novartis ...

“This expanded access enables Novartis to deploy Schrödinger’s full suite of ... through a computational ‘predict first’ ...

THE Philippine Press Institute (PPI) has spearheaded a health reporting workshop to help local journalists gain a deeper ...

With the seven-year experience of attending the China International Import Expo, Guan Hong, a senior executive at Novartis China believes CIIE is one of the best windows to introduce new medicines ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the third quarter of 2024 and provided a business update. In a separate press release issued earlier ...

Watch out, Gilead and Novartis: there's a new CAR-T in town ... as much of the reporting involved in REMS is already reported through other registries, CEO Christian Itin, Ph.D., said on the call. “It ...